CVS vs TECH
CVS Health Corp (CVS) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the CVS and TECH stock pages for the full models.
Not investment advice.